We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Patterson Cos. (PDCO) Dips More Than Broader Markets: What You Should Know
Read MoreHide Full Article
Patterson Cos. (PDCO - Free Report) closed the most recent trading day at $33.83, moving -1.4% from the previous trading session. This change lagged the S&P 500's daily loss of 1.16%. At the same time, the Dow lost 1.02%, and the tech-heavy Nasdaq lost 1.14%.
Coming into today, shares of the medical supplies maker had gained 5.47% in the past month. In that same time, the Medical sector gained 2.42%, while the S&P 500 lost 0.27%.
Investors will be hoping for strength from Patterson Cos. as it approaches its next earnings release. The company is expected to report EPS of $0.40, up 25% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $1.57 billion, up 3.23% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $2.50 per share and revenue of $6.72 billion, which would represent changes of +3.31% and +3.79%, respectively, from the prior year.
Investors should also note any recent changes to analyst estimates for Patterson Cos.These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Patterson Cos. currently has a Zacks Rank of #1 (Strong Buy).
In terms of valuation, Patterson Cos. is currently trading at a Forward P/E ratio of 13.73. Its industry sports an average Forward P/E of 23.13, so we one might conclude that Patterson Cos. is trading at a discount comparatively.
Investors should also note that PDCO has a PEG ratio of 1.49 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Medical - Dental Supplies stocks are, on average, holding a PEG ratio of 2.11 based on yesterday's closing prices.
The Medical - Dental Supplies industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 39, which puts it in the top 16% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Patterson Cos. (PDCO) Dips More Than Broader Markets: What You Should Know
Patterson Cos. (PDCO - Free Report) closed the most recent trading day at $33.83, moving -1.4% from the previous trading session. This change lagged the S&P 500's daily loss of 1.16%. At the same time, the Dow lost 1.02%, and the tech-heavy Nasdaq lost 1.14%.
Coming into today, shares of the medical supplies maker had gained 5.47% in the past month. In that same time, the Medical sector gained 2.42%, while the S&P 500 lost 0.27%.
Investors will be hoping for strength from Patterson Cos. as it approaches its next earnings release. The company is expected to report EPS of $0.40, up 25% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $1.57 billion, up 3.23% from the year-ago period.
For the full year, our Zacks Consensus Estimates are projecting earnings of $2.50 per share and revenue of $6.72 billion, which would represent changes of +3.31% and +3.79%, respectively, from the prior year.
Investors should also note any recent changes to analyst estimates for Patterson Cos.These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Patterson Cos. currently has a Zacks Rank of #1 (Strong Buy).
In terms of valuation, Patterson Cos. is currently trading at a Forward P/E ratio of 13.73. Its industry sports an average Forward P/E of 23.13, so we one might conclude that Patterson Cos. is trading at a discount comparatively.
Investors should also note that PDCO has a PEG ratio of 1.49 right now. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Medical - Dental Supplies stocks are, on average, holding a PEG ratio of 2.11 based on yesterday's closing prices.
The Medical - Dental Supplies industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 39, which puts it in the top 16% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.